Mastodon

Loxone-400 (Tablets) Instructions for Use

Marketing Authorization Holder

Micro Labs Limited (India)

ATC Code

J01MA06 (Norfloxacin)

Active Substance

Norfloxacin (Rec.INN registered by WHO)

Dosage Form

Bottle Rx Icon Loxone-400 Film-coated tablets, 400 mg: 10 or 100 pcs.

Dosage Form, Packaging, and Composition

Film-coated tablets orange in color, oval, biconvex, with a score on one side.

1 tab.
Norfloxacin 400 mg

Excipients: microcrystalline cellulose, corn starch, colloidal silicon dioxide, methylparaben, propylparaben, purified talc, magnesium stearate, purified water.

Film coating composition: hypromellose, Tabcoat TS-0-2003 orange (the composition of this ingredient includes titanium dioxide and sunset yellow dye), propylene glycol, purified talc.

10 pcs. – blisters (1) – cardboard packs.
10 pcs. – blisters (10) – cardboard packs.

Clinical-Pharmacological Group

Antibacterial drug of the fluoroquinolone group

Pharmacotherapeutic Group

Antimicrobial agent – fluoroquinolone

Pharmacological Action

A broad-spectrum antimicrobial synthetic agent of the fluoroquinolone group. It has a bactericidal effect. By suppressing DNA gyrase, it disrupts the DNA supercoiling process.

It is highly active against most gram-negative bacteria: Escherichia coli, Salmonella spp., Shigella spp., Proteus spp., Morganella morganii, Klebsiella spp. (including Klebsiella pneumoniae), Enterobacter spp., Serratia spp., Citrobacter spp., Yersinia spp., Providencia spp., Haemophilus influenzae, Pseudomonas aeruginosa, Neisseria gonorrhoeae, Neisseria meningitidis.

It is active against some gram-positive bacteria (including Staphylococcus aureus).

Anaerobic bacteria are resistant to norfloxacin, while Enterococcus spp. and Acinetobacter spp. are poorly sensitive.

It is resistant to the action of β-lactamases.

Pharmacokinetics

When taken orally, approximately 30-40% is absorbed; food intake reduces the rate of absorption. Plasma protein binding is 14%. Norfloxacin is well distributed in the tissues of the urogenital system. It crosses the placental barrier. About 30% is excreted unchanged in the urine.

Indications

Infectious and inflammatory diseases caused by microorganisms sensitive to norfloxacin, including diseases of the urinary tract, prostate gland, gastrointestinal tract, gonorrhea, prevention of recurrences of urinary tract infections, bacterial infections in patients with granulocytopenia, “traveler’s diarrhea”.

ICD codes

ICD-10 code Indication
A09 Other and unspecified gastroenteritis and colitis of infectious origin
A54 Gonococcal infection
K81.0 Acute cholecystitis
K81.1 Chronic cholecystitis
K83.0 Cholangitis
N10 Acute tubulointerstitial nephritis (acute pyelonephritis)
N11 Chronic tubulointerstitial nephritis (chronic pyelonephritis)
N30 Cystitis
N34 Urethritis and urethral syndrome
N41 Inflammatory diseases of prostate
N74.3 Gonococcal inflammatory diseases of female pelvic organs
N77.1 Vaginitis, vulvitis and vulvovaginitis in infectious and parasitic diseases classified elsewhere
Z29.2 Other prophylactic chemotherapy (administration of antibiotics for prophylactic purposes)
ICD-11 code Indication
1A40.Z Infectious gastroenteritis or colitis, unspecified
1A7Z Gonococcal infection, unspecified
1F23.10 Candidiasis of vulva and vagina
1F65 Enterobiasis
1H0Z Unspecified infection
DC12.0Z Acute cholecystitis, unspecified
DC12.1 Chronic cholecystitis
DC13 Cholangitis
GA91.Z Inflammatory and other diseases of prostate, unspecified
GB50 Acute tubulo-interstitial nephritis
GB51 Acute pyelonephritis
GB55.Z Chronic tubulo-interstitial nephritis, unspecified
GB5Z Renal tubulo-interstitial diseases, unspecified
GC00.Z Cystitis, unspecified
GC02.Z Urethritis and urethral syndrome, unspecified
QC05.Y Other specified prophylactic measures
1A71 Gonococcal pelviperitonitis
GA05.Z Inflammatory diseases of female pelvic organs, unspecified
1A94.0 Genital or urogenital tract infection caused by Herpes simplex virus
GA41 Ulcerative or erosive diseases of vulva

Dosage Regimen

The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen.

Determine the dosage individually based on the type and severity of the infection.

For uncomplicated urinary tract infections, take 400 mg orally twice daily for 7 to 10 days.

For complicated urinary tract infections, take 400 mg orally twice daily for 10 to 21 days.

For prostatitis, take 400 mg orally twice daily for 28 days.

For gonorrhea, administer a single 800 mg dose.

For gastrointestinal infections such as “traveler’s diarrhea”, take 400 mg orally twice daily for 3 to 5 days.

For prophylaxis of recurrent urinary tract infections, take 200 mg once daily at bedtime.

For patients with renal impairment, adjust the dose if creatinine clearance is below 30 mL/min; a recommended regimen is 400 mg once daily.

Take tablets with a full glass of water, at least 2 hours before or 2 hours after consuming antacids or products containing magnesium, aluminum, iron, zinc, or calcium.

Complete the entire prescribed course of therapy, even if symptoms improve.

Adverse Reactions

From the digestive system: nausea, heartburn, anorexia, diarrhea, abdominal pain.

From the CNS: headache, dizziness, feeling of fatigue, sleep disorders, irritability, feeling of anxiety.

Allergic reactions: skin rash, itching, angioedema.

From the urinary system: interstitial nephritis.

Contraindications

Pregnancy, lactation (breastfeeding), childhood and adolescence (up to 15 years), glucose-6-phosphate dehydrogenase deficiency, hypersensitivity to norfloxacin and other quinolone drugs.

Use in Pregnancy and Lactation

Norfloxacin is contraindicated during pregnancy and lactation (breastfeeding), since experimental studies have established that it causes arthropathy.

Use in Hepatic Impairment

Should be used with caution in patients with severe liver function impairment.

Use in Renal Impairment

Should be used with caution in patients with severe renal function impairment.

Pediatric Use

Contraindicated in childhood and adolescence (up to 15 years).

Special Precautions

Should be used with caution in patients with epilepsy, convulsive syndrome of other etiology, and with severe impairment of renal and liver function. During treatment, patients should receive a sufficient amount of fluid (under diuresis control).

Norfloxacin should be taken no less than 2 hours before or 2 hours after taking antacids or preparations containing iron, zinc, magnesium, calcium, or sucralfate.

Drug Interactions

With simultaneous use of norfloxacin with warfarin, the anticoagulant effect of the latter is enhanced.

With simultaneous use of norfloxacin with cyclosporine, an increase in the concentration of the latter in blood plasma is noted.

With simultaneous administration of norfloxacin and antacids or preparations containing iron, zinc, magnesium, calcium, or sucralfate, the absorption of norfloxacin is reduced due to the formation of chelates with metal ions (the interval between their intake should be at least 4 hours).

With simultaneous administration, Norfloxacin reduces the clearance of theophylline by 25%, therefore, when used concomitantly, the dose of theophylline should be reduced.

Simultaneous administration of norfloxacin with drugs that have a potential ability to reduce blood pressure may cause a sharp decrease in it. In this regard, in such cases, as well as with simultaneous administration of barbiturates and anesthetic agents, heart rate, blood pressure, and ECG parameters should be monitored. Simultaneous use with drugs that lower the epileptic threshold may lead to the development of epileptiform seizures.

It reduces the effect of nitrofurans.

Storage Conditions

Store at 2°C (36°F) to 25°C (77°F). Keep in original packaging, protected from light. Keep out of reach of children.

Dispensing Status

Rx Only

Important Safety Information

This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.

Medical Disclaimer

TABLE OF CONTENTS